Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
43 minutes ago · Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent stock. Explore the latest details on Dr. Reddy's Laboratories, including: Last traded price 6430.0, Market capitalization: 107195.75, Volume: 923, Price-to-earnings ratio 19.22, Earnings per share 334.37. Get a comprehensive understanding of Dr. Reddy's Laboratories with our coverage of both fundamental and technical indicators. Stay informed about ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
1 day ago · Acquisition of Nicotinell will give Dr Reddy’s access to key global customers, markets, talent Analysts are jittery as the acquired portfolio is a slow-growing business Dr Reddy’s Laboratories ...
Dr Reddys Labs Share Price: Find the latest news on Dr Reddys Labs Stock Price. Get all the information on Dr Reddys Labs with historic price charts for NSE / BSE.
7 hours ago · Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 1.64 lakh shares today, compared to the daily average of 6.23 lakh shares in last one month.
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Hyderabad-based Dr Reddy Laboratories, one of the more-noticed names in the pharma business, has been in the headlines for the past few days now. In a recent development, the company shares jumped ...
Jun 27, 2024 · The acquisition being made by Dr. Reddy’s Laboratories SA is on an upfront cash consideration of GBP 458 million and additional performance-based contingent cash payments of up to GBP 42 million ...
Dr.reddy's Laboratories Ltd is a Public incorporated on 24 February 1984. It is classified as Non-government company and is registered at Registrar of Companies, ROC Hyderabad. Its authorized share capital is Rs. 1,450,000,000 and its paid up capital is Rs. 834,091,330.
Product Websites. Sapropterin Dihydrochloride Patient Support Program. DOXOrubicin HCI Liposome. Bivalirudin. Sumatriptan Injection. Co-pay Card Programs. Fingolimod Capsules 0.5 mg Co-pay Card. Lenalidomide Capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, and 25 mg Co-pay Card. Pyrimethamine Tablets USP, 25 mg Co-pay Card.
At Dr. Reddy's Laboratories, we are dedicated to making a meaningful impact on global healthcare through precision manufacturing and innovation. With a legacy of excellence, we are a leading force in the pharmaceutical industry. We operate 19 state-of-the-art manufacturing plants across Hyderabad, Vizag, Baddi, Mexico, Shreveport, and Mirfield, comprising 8 OSD facilities, 3 Injectables facilities, and 8 API facilities. Benchmarking manufacturing processes and continuous operational ...
6 days ago · Top Gainers and Losers Today : The Sensex lost 210.45 points, or -0.27, to settle at 79243.18, while the Nifty lost 33.9 points, or -0.14, to close at 24044.5.
Gusu District (simplified Chinese: 姑苏区; traditional Chinese: 姑蘇區; pinyin: Gūsū Qū) is one of five urban districts and the main district of Suzhou, Jiangsu province, China. It was created on 1 September 2012 by the merger of the three former districts of Canglang, Pingjiang, and Jinchang.
The pavilion is part of the UNESCO World Heritage-listed Classical Gardens of Suzhou, a collection of meticulously designed gardens that showcase traditional Chinese gardening principles. Its exact address is No. 3 Canglang Pavilion Street, Gusu District, Suzhou, Jiangsu Province, China. To get there, you can choose the following ways:
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Hassle-Free Refund with 15 Business Days. A full refund is guaranteed if you received products that are damaged, defective, or improperly handled (For customized products, 80% Hassle-Free Refunds are guaranteed under the same circumstances).
You can contact us any way that is convenient for you. We are available 24/7 via fax, email or telephone. Pingjiang Tiandi Commercial Center, Gusu District, Suzhou City, Jiangsu Province, PRC 215000. +86- (151)51493186. info@landercable.com.
About Dr. Reddy’s Laboratories Ltd: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. ...
in Dr. Reddy’s Laboratories Inc in USA, a wholly owned subsidiary of the Company (US WOS), subject to approval of the members of the Company, with effect from the date of appointment which shall be on or after the date of such approval by the members. Mr. Vishal Reddy is the son of Mr. K Satish Reddy, Chairman (Whole-time Director) of the Company. Once approval is received, he will be appointed
Hyderabad 500 050, INDIA. +91.40.2309 5272. Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
